A scientist works in a laboratory at the Novavax facility in Gaithersburg, Maryland, US. (Photographer: Jon Cherry/Bloomberg via Getty Images)
Novavax focuses on variant-specific vaccines in expanded deal with South Korean manufacturer
The rollercoaster ride for Novavax’s Covid-19 vaccine has finally resulted in an emergency use authorization from the FDA. However, as the Omicron variant spreads, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
